262 related articles for article (PubMed ID: 9822768)
1. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.
Haddjeri N; Blier P; de Montigny C
J Neurosci; 1998 Dec; 18(23):10150-6. PubMed ID: 9822768
[TBL] [Abstract][Full Text] [Related]
2. Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.
Besson A; Haddjeri N; Blier P; de Montigny C
Eur Neuropsychopharmacol; 2000 May; 10(3):177-88. PubMed ID: 10793320
[TBL] [Abstract][Full Text] [Related]
3. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments.
Haddjeri N; Szabo ST; de Montigny C; Blier P
Neuropsychopharmacology; 2000 Apr; 22(4):346-56. PubMed ID: 10700654
[TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
Moser PC; Sanger DJ
Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
[TBL] [Abstract][Full Text] [Related]
5. Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.
Haddjeri N; De Montigny C; Curet O; Blier P
Eur J Pharmacol; 1998 Feb; 343(2-3):179-92. PubMed ID: 9570466
[TBL] [Abstract][Full Text] [Related]
6. Agonist occupation of serotonin1A receptors in the rat hippocampus prevents their inactivation by pertussis toxin.
Hadrava V; Blier P; de Montigny C
Neuroscience; 1994 Jul; 61(1):21-30. PubMed ID: 7969892
[TBL] [Abstract][Full Text] [Related]
7. Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.
Haddjeri N; Blier P; de Montigny C
J Affect Disord; 1998 Dec; 51(3):255-66. PubMed ID: 10333981
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain.
Rueter LE; Blier P
Br J Pharmacol; 1999 Feb; 126(3):627-38. PubMed ID: 10188973
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of antidepressants and corticosterone on the sensitivity of hippocampal CA1 neurons to 5-HT1A and 5-HT4 receptor activation.
Bijak M; Zahorodna A; Tokarski K
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):491-8. PubMed ID: 11383709
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
Chaput Y; de Montigny C; Blier P
Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
[TBL] [Abstract][Full Text] [Related]
11. Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission.
Haddjeri N; Ortemann C; de Montigny C; Blier P
Eur Neuropsychopharmacol; 1999 Sep; 9(5):427-40. PubMed ID: 10523050
[TBL] [Abstract][Full Text] [Related]
12. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
13. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release.
Sharp T; Gartside SE; Umbers V
Eur J Pharmacol; 1997 Feb; 320(1):15-9. PubMed ID: 9049597
[TBL] [Abstract][Full Text] [Related]
14. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain.
El Mansari M; Lecours M; Blier P
Psychopharmacology (Berl); 2015 Jul; 232(13):2343-52. PubMed ID: 25665528
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists.
Blier P; de Montigny C
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S42-8. PubMed ID: 1702486
[TBL] [Abstract][Full Text] [Related]
18. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Romero L; Artigas F
J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
[TBL] [Abstract][Full Text] [Related]
19. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.
Bermack JE; Debonnel G
J Psychopharmacol; 2007 Jan; 21(1):85-92. PubMed ID: 16533864
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
